Dr Antonius VanDongen | Unlocking the Mysteries of Alzheimer’s Disease with the Arc Gene
Our vulnerability to developing diseases and conditions depends upon a complex interaction between our genes, lifestyle, and environmental factors. Alzheimer’s disease is no exception to this, and sadly, it remains without a cure. Dr Antonius VanDongen and his team from Duke University are studying the mechanisms underlying learning and memory, specifically focusing on the activity-regulated cytoskeletal memory gene Arc. Their work is driving forward our understanding of the memory problems that characterise Alzheimer’s disease.
Upkeeping Memories: The Process of Memory Consolidation
Memory consolidation is the process by which our brains store and strengthen newly acquired information. It happens after we learn something or experience a new situation. This information first enters short-term memory. Then, the connections between brain cells representing this specific memory are strengthened. As these connections strengthen over time, the information is transferred to long-term memory, where it is stored and solidified.
Imagine your brain as an extensive library of books, each representing a memory. When you experience something new, your brain starts writing a new book for its library. Memory consolidation is a process in which the brain ensures the books in the library are well organised. If you repeatedly encounter a similar memory, the draft of that book becomes better and better. This revision process uses all the resources the brain has to offer (such as previous memories) to rewrite the new book and find the best space in the library so that it can stay on an appropriate shelf for a long time and you can access it easily when you need it.
In some disorders, such as Alzheimer’s disease, the process of memory consolidation becomes increasingly impaired over time, leading to memory difficulties and, eventually, detriments to an individual’s ability to manage self-care and other essential daily tasks. Dr Antonius VanDongen and his team from Duke University seek to understand the roles of specific genes in the complex but critical process of memory consolidation.
The Role of the Arc Gene
Dr VanDongen is particularly interested in the activity-regulated cytoskeletal-associated protein known as Arc. Deactivation of the Arc gene in mice disrupted long-term memory consolidation, while short-term memory remained unchanged. This means that the Arc gene is involved in specific processes of turning short-term memories into long-term memories, highlighting its importance for memory formation and retention.
Arc acts as a special messenger on synapses, small bridges between our brain cells that allow information to pass from one cell to another. When we learn or experience something new, the Arc gene becomes active and helps our brain to remember and consolidate that experience. As such, it is vital to making our memories solid and long-lasting.
Activating and Deactivating the Arc Gene
Working with How-Wing Leung and Gabriel Wei Quan Foo, Dr Vandongen studied what happens when the Arc gene is deactivated. The (de)activation of a gene and related processes is called gene expression, and the team was able to deactivate the Arc gene in cultured neuronal networks derived from rat brains. Their findings were intriguing.
Disabling the function of Arc altered the gene expression of 1,900 other genes. In other words, altering the expression of the Arc gene directly impacts the function of hundreds of other genes. Some of these genes were related to synaptic functions or to the functions of other vital brain processes that are involved in memory, learning, and cognition. Significantly, many of these genes are involved in the development of Alzheimer’s disease and other forms of dementia. Dr VanDongen’s study showed that the Arc gene is essential for consolidating individual memories and is critical to overall brain function. These findings open up a new avenue of research for fully understanding how memories are formed and maintained.
Epigenetic insights into Arc
Recent research revealed fascinating insights into the epigenetic mechanisms that underlie Arc’s function. Epigenetics refers to complex modifications of how genes work without altering the genes themselves. So, how does Arc control the activity of other genes?
Dr VanDongen and his colleagues suggest that Arc might affect the ‘instructions’ that other genes receive. One possible way is to influence the structure of chromatin, a combination of DNA and protein that regulates gene activity. The effect of disabling Arc can be thought of as a series of falling dominoes. Arc’s deactivation triggers a cascade of events, starting with changes in chromatin structure. These changes then affect other proteins and molecules, ultimately deactivating multiple genes involved in memory consolidation and synaptic function. This complex interplay is part of the intricate machinery that allows Arc to significantly impact memory and cognitive functions.
Implications for Future Research in Alzheimer’s Disease
Due to Arc’s role in memory and learning, it offers an important new therapeutic target for slowing down the progression of Alzheimer’s disease. By targeting the Arc gene, Dr VanDongen envisions that scientists could potentially develop new therapies for Alzheimer’s disease that would work on modulating the gene’s activity. Consequently, this would influence the expression of other genes that influence the synaptic functions in neurological disorders, ultimately aiming to address the cognitive dysfunction and memory deficits observed in Alzheimer’s disease.
SHARE
DOWNLOAD E-BOOK
REFERENCE
https://doi.org/10.33548/SCIENTIA981
MEET THE RESEARCHER
Dr Antonius VanDongen
School of Medicine
Duke University
Durham
USA
Dr Antonius VanDongen is an Associate Professor at Duke University, USA. After completing his PhD in Biophysics at the University of Leiden in the Netherlands, he moved to Texas, USA, to work at Baylor College of Medicine. He started working at Duke University in 1992 and at the Duke-NUS Graduate Medical School in Singapore. His extensive background spans pharmacology, electrophysiology, molecular and cellular neurobiology, and computational neuroscience. He is also interested in drug development, and his current research interests include the role of the Arc (activity-regulated cytoskeleton) gene in Alzheimer’s disease and the development of related therapeutics.
CONTACT
E: antonius.vandongen@duke.edu
W: medschool.duke.edu/profile/antonius-m-j-vandongen
www.duke-nus.edu.sg/directory/detail/antonius-m-j-van-dongen
FUNDING
National Institutes of Health
FURTHER READING
HW Leung, GWQ Foo, AMJ VanDongen, Arc regulates transcription of genes for plasticity, excitability and Alzheimer’s disease, Biomedicines, 2022, 10(8), 1946. DOI: https://doi.org/10.3390/biomedicines10081946
REPUBLISH OUR ARTICLES
We encourage all formats of sharing and republishing of our articles. Whether you want to host on your website, publication or blog, we welcome this. Find out more
Creative Commons Licence (CC BY 4.0)
This work is licensed under a Creative Commons Attribution 4.0 International License.
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
SUBSCRIBE NOW
Follow Us
MORE ARTICLES YOU MAY LIKE
Professor Nicola Curtin | Potential for Improving Cancer Treatment by Optimising Drug Scheduling
Cancers often develop because of faulty DNA repair systems. PARP inhibitors (PARPi) are a class of targeted anti-cancer drugs that exploit this weakness, by inhibiting a complementary DNA repair system, to selectively target the tumour. However, these medicines need to be taken every day, creating a burden on patients and reducing the options for combination with other anticancer therapies. Professor Nicola Curtin and her team at Newcastle University investigated how long different PARPi stay active in cancer cells after a single dose and how this influences their effectiveness when combined with another anti-cancer drug.
Feeding Bovine Colostrum to Chickens Creates Healthier Guts and Better Growth
A research team at the University of Maryland School of Medicine has discovered that a simple food supplement, specifically defatted bovine colostrum, can significantly enhance chicken gut health, reduce inflammation, and improve growth efficiency. The findings have implications for both animal welfare and human health under the One Health concept.
Dr Alexander Scholze | Digital Transformation in the Workplace: Navigating the Balance Between Demands and Resources
What if your digital tools, designed to help you, became the very reason for your burnout? In today’s rapidly evolving digital landscape, organisations face the challenge of implementing technological changes while safeguarding employee well-being. Dr Alexander Scholze has developed a theoretical framework that comprehensively examines how digitalisation affects workplace dynamics, particularly focusing on job demands and resources. His research offers valuable insights for organisations seeking to harness the benefits of digital transformation while mitigating potential negative impacts on employee health and motivation.
Dr Jiexin Deng | Optimising Warfarin Treatments for Chinese Patients
Warfarin is a commonly prescribed oral blood thinner used for the prevention and treatment of thromboembolic conditions. The wide variability in these conditions, that may range from deep vein thrombosis to heart valve replacement, adds to the complexity in determining dosing requirements among patients. Dr Jiexin Deng and colleagues at Zhengzhou Cardiovascular Hospital and Huaihe Hospital of Henan University in China have investigated the suitability of various pharmacogenetic algorithms based on different ethnicities to assist with warfarin dosing for the Chinese population, hoping to improve clinical outcomes and reduce the incidence of unwanted side effects.